MAGGI, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 16.962
AS - Asia 8.099
EU - Europa 5.941
SA - Sud America 2.227
Continente sconosciuto - Info sul continente non disponibili 685
AF - Africa 194
OC - Oceania 11
Totale 34.119
Nazione #
US - Stati Uniti d'America 16.664
SG - Singapore 3.036
IT - Italia 1.812
BR - Brasile 1.791
VN - Vietnam 1.702
CN - Cina 1.340
HK - Hong Kong 1.232
IE - Irlanda 881
SE - Svezia 602
DE - Germania 582
FR - Francia 534
RU - Federazione Russa 395
UA - Ucraina 374
GB - Regno Unito 314
AR - Argentina 182
FI - Finlandia 169
BD - Bangladesh 154
IN - India 131
MX - Messico 108
ID - Indonesia 103
CA - Canada 100
JP - Giappone 91
EC - Ecuador 72
IQ - Iraq 59
ZA - Sudafrica 51
NL - Olanda 48
CO - Colombia 46
PL - Polonia 41
PY - Paraguay 40
ES - Italia 36
AT - Austria 31
UZ - Uzbekistan 31
CL - Cile 30
NG - Nigeria 30
PK - Pakistan 28
MA - Marocco 26
TR - Turchia 25
VE - Venezuela 25
BE - Belgio 22
PE - Perù 21
SA - Arabia Saudita 21
EG - Egitto 18
KE - Kenya 18
LT - Lituania 17
NP - Nepal 16
JM - Giamaica 14
PH - Filippine 14
UY - Uruguay 14
CR - Costa Rica 13
MY - Malesia 13
AZ - Azerbaigian 12
CZ - Repubblica Ceca 12
DZ - Algeria 12
TN - Tunisia 12
MD - Moldavia 11
AE - Emirati Arabi Uniti 10
HN - Honduras 10
JO - Giordania 10
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
LB - Libano 9
AU - Australia 8
BG - Bulgaria 8
ET - Etiopia 8
IL - Israele 8
OM - Oman 8
BB - Barbados 7
EU - Europa 7
HR - Croazia 7
NI - Nicaragua 7
RO - Romania 7
GT - Guatemala 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
AL - Albania 5
CI - Costa d'Avorio 5
PR - Porto Rico 5
PT - Portogallo 5
BO - Bolivia 4
HU - Ungheria 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
CU - Cuba 3
CY - Cipro 3
EE - Estonia 3
GA - Gabon 3
GE - Georgia 3
GR - Grecia 3
LK - Sri Lanka 3
PA - Panama 3
QA - Qatar 3
TZ - Tanzania 3
AM - Armenia 2
BH - Bahrain 2
BW - Botswana 2
CH - Svizzera 2
DK - Danimarca 2
DM - Dominica 2
Totale 33.410
Città #
San Jose 1.922
Ashburn 1.564
Singapore 1.516
Fairfield 1.289
Hong Kong 1.223
Jacksonville 961
Milan 916
Dublin 864
Council Bluffs 838
Princeton 737
Dallas 705
Chandler 652
Wilmington 636
Woodbridge 490
The Dalles 467
Houston 445
Nyköping 438
Seattle 426
Boardman 412
Cambridge 381
Ho Chi Minh City 377
Lauterbourg 370
Dong Ket 334
Beijing 323
Chicago 319
Los Angeles 262
New York 201
Hanoi 197
San Diego 178
Redwood City 176
Santa Clara 165
São Paulo 156
Ogden 142
Ann Arbor 138
Washington 130
Helsinki 128
Rome 125
Salt Lake City 114
London 107
Tokyo 84
Como 70
Tampa 67
Mexico City 66
Buffalo 64
Phoenix 64
Elk Grove Village 58
Munich 58
Haiphong 57
Frankfurt am Main 56
Rio de Janeiro 53
Lancaster 49
Guangzhou 48
Norwalk 47
Orem 45
Da Nang 42
Brasília 40
Varese 40
Atlanta 38
Denver 36
Warsaw 36
Shanghai 35
San Francisco 33
Belo Horizonte 32
Brooklyn 31
Chennai 30
Abuja 29
Biên Hòa 28
Porto Alegre 28
Shenzhen 28
Montreal 27
Nuremberg 27
Stockholm 26
Tashkent 26
Dhaka 25
Sterling 25
Hangzhou 24
Baghdad 23
Curitiba 23
Guarulhos 23
Johannesburg 23
Toronto 23
Campinas 22
Miami 22
Ninh Bình 22
Poplar 22
Quito 21
Turku 21
Boston 19
Brussels 19
Falkenstein 19
Guayaquil 19
Manchester 19
Moscow 19
Ribeirão Preto 19
Salvador 19
Thái Bình 19
Buenos Aires 18
Can Tho 18
Kilburn 18
Tianjin 18
Totale 22.884
Nome #
Characterization of a lineage C.36 SARS-CoV-2 isolate with reduced susceptibility to neutralization circulating in Lombardy, Italy 480
Torque Teno Virus: A Promising Biomarker in Kidney Transplant Recipients 280
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19 267
Previous humoral immunity to the endemic seasonal alphacoronaviruses NL63 and 229E is associated with worse clinical outcome in COVID-19 and suggests original antigenic sin 239
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy 226
Viral hepatitis 216
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 212
Torque Teno virus: any pathological role in liver transplanted patients? 200
Torquetenovirus detection in exosomes enriched vesicles circulating in human plasma samples 189
Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9 181
Tyrosine kinase inhibitors play an antiviral action in patients affected by chronic myeloid leukemia: a possible model supporting their use in the fight against SARS-CoV-2 180
An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children 171
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age 170
Comparative evaluation of five rapid methods for identifying subtype 1b and 2c hepatitis C virus isolates 170
Impact of Microbial Metabolites on Microbiota–Gut–Brain Ax-is in Inflammatory Bowel Disease 169
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation 169
Immunobiology of the Torque teno viruses and other anelloviruses 164
Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection 164
An episode of oral mucositis after the first administration of the ChAdOx1 COVID-19 vaccine 163
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021 161
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients 155
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease 148
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022 144
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 143
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients 143
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine 135
Enhanced in vitro virus expression using 3-dimensional cell culture spheroids for infection 135
Zinc Oral Supplementation Induces a Significant Rise of TRECs and T CD4+NaiVe and Prevents the Increase of Ttv Viral Load after Stem Cell Transplantation: The Zenith Study 134
How Current Direct-Acting Antiviral and Novel Cell Culture Systems for HCV are Shaping Therapy and Molecular Diagnosis of Chronic HCV Infection 134
Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy 134
TTV GUIDE IT - A randomised controlled trial to compare the safety, tolerability and preliminary efficacy between standard and torque teno virus-guided immunosuppression in stable adult kidney transplant recipients with low immunological risk in the first year after transplantation - a trial protocol 132
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients 131
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 130
Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy 129
Sialic acid moieties and 5-HT2a: two faces of the same receptor for JC virus? 127
La vaccinazione con la glicoproteina B del virus Herpes Simplex tipo 1 protegge contro l’herpes genitale 126
High prevalence of TT virus (TTV) and TTV-like minivirus in cervical swabs 125
HIV-1 NAT minipool during the pre-seroconversion window period: Detection of a repeat blood donor 125
Asymptomatic SARS-CoV-2 vaccine breakthrough infections in health care workers identified through routine universal surveillance testing 125
Absence of xenotropic murine leukemia virus-related virus in italian patients affected by chronic fatigue syndrome, fibromyalgia, or rheumatoid arthritis 124
Hyaluronan: A neuroimmune modulator in the microbiota-gut axis 124
Can interferon-ribavirin effectively treat patients who did not respond to a first conventional therapy by interferon? 120
Detection of Torquetenovirus and Redondovirus DNA in Saliva Samples from SARS-CoV-2-Positive and -Negative Subjects 118
Analysis of immune escape variants from antibody‐based therapeutics against covid‐19: A systematic review 117
Role of Low-Molecular-Weight Heparin in Hospitalized Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study 117
Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022 116
Anelloviruses and immune competence 116
Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus (TTV) viremia, the new surrogate marker of immune competence 116
Zika Virus: Implications for Public Health 115
TTV and other anelloviruses: The astonishingly wide spread of a viral infection 114
SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients 114
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: Old drugs for an old disease 112
Imported SARS-COV-2 Variant P.1 Detected in Traveler Returning from Brazil to Italy 111
Immunosuppressive monoclonal antibodies: current and next generation 110
TT virus in the nasal secretions of children with acute respiratory diseases: Relations to viremia and disease severity 110
Sialic acid moieties and 5-HT(2a): Two faces of the same receptor for JC virus? 109
Assessment of prevalence and load of torquetenovirus viremia in a large cohort of healthy blood donors 109
Human anelloviruses and the central nervous system 108
A novel rolling circle amplification assay to detect members of the family Anelloviridae in pigs and humans 108
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 108
Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy 108
Torquetenovirus (TTV) load is associated with mortality in Italian elderly subjects 107
Torquetenovirus infection and ciliary dysmotility in children with recurrent pneumonia 107
Influence of hepatitis C virus (HCV) genotype, HCV RNA load, and alanine aminotransferase level on reduction of HCV RNA after a single administration of interferon alpha 107
A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers 107
JC virus DNA in healthy brain tissue: a challenge for progressive multifocal leukoencephalopathy diagnosis 106
Attempt to classify the clinical impact of DNA viruses according to the ability to activate the innate immune system 106
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution 106
TT virus loads and lymphocyte subpopulations in children with acute respiratory diseases 104
Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy 103
Anellovirus 102
Getting the most from the Ebola vaccine success 102
TT virus infection of periodontal tissues: A controlled clinical and laboratory pilot study 100
In vitro sensitivity of human metapneumovirus to type i interferons 100
Anellovirus 99
Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patients 99
Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients 99
Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease 98
COVID-19 emergency management: From the reorganization of the endoscopy service to the verification of the reprocessing efficacy 98
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody 98
Anellovirus 97
Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor–recipient differences in concentration of neutralizing antibodies 97
Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans 96
Kinetics of anti-SARS-COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stability 96
Performance Assessment of the LIAISON® SARS-CoV-2 Antigen Assay On Nasopharyngeal Swabs 96
5-HT2a antagonists as a new treatment for JCV-associated progressive multifocal leukoencephalopathy 95
High prevalence of TT virus viremia in Italian patients, regardless of age, clinical diagnosis, and previous interferon treatment 95
Virome and Inflammasomes, a Finely Tuned Balance with Important Consequences for the Host Health 95
Role of Hematopoietic Cells in the Maintenance of Chronic Human Torquetenovirus Plasma Viremia 95
Expression of MxA mRNA in PBL from chronic hepatitis C patients and response to interferon-alpha therapy 94
Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia 94
Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disorders 94
Cell therapies for treatment of human immunodeficiency virus infection 94
Human bocavirus in Italian patients with respiratory diseases 93
Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients 93
Hypothesis: Central nervous system delivery of cyclosporine A for therapy of progressive multifocal leukoencephalopathy 93
The Virome and its Major Component, Anellovirus, a Convoluted System Molding Human Immune Defenses and Possibly Affecting the Development of Asthma and Respiratory Diseases in Childhood 92
During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein 92
Lack of Marseillevirus DNA in immunocompetent and immunocompromised Italian patients 92
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 92
Totale 13.063
Categoria #
all - tutte 201.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 201.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.679 0 386 65 113 52 129 181 231 165 574 297 486
2022/20232.586 442 148 149 151 81 638 30 256 370 195 58 68
2023/20242.847 233 234 256 569 574 483 49 79 216 46 17 91
2024/20255.308 19 39 885 102 64 381 98 166 624 375 811 1.744
2025/202613.890 669 800 1.411 2.889 731 357 2.449 980 1.709 894 600 401
2026/20271.076 328 748 0 0 0 0 0 0 0 0 0 0
Totale 34.119